ImmuCell Corporation

02/09/2026 | Press release | Distributed by Public on 02/09/2026 15:07

Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers, Election of Directors.
Two Company directors (Steven A. Rosgen and Bryan K. Gathagan) have separately given notice that they prefer not to run for re-election at the 2026 Annual Meeting of Shareholders. Both have been supportive of the Company's new strategic direction and management team, but each cited time constraints from full-time leadership roles at their respective companies. The Nominating Committee has recently been evaluating possible changes in composition of the Board of Directors and will now factor those future retirements into its ongoing work.
ImmuCell Corporation published this content on February 09, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 09, 2026 at 21:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]